Session Chair Profile
Ph.D., Vice President & Head of Global Research, Roche Molecular Systems, Inc.
Dr. Koch has been in his current role of VP and Head of Global Research for Roche Molecular Systems since 2005. As a member of the Executive Leadership Team, he sits on the Life Cycle and Business Development committees, and chairs the Research Portfolio Committee. He is responsible for all RMD research and early development activities, including research efforts associated with biomarker discovery and validation, the development of new platform technologies, and fundamental improvements in the performance of existing products and technologies. He joined RMS in 1998 as a Research Leader and helped lead the launch of the AmpliChip CYP450 assay.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: There are technical hurdles related to liquid biopsy but these appear to be solvable. One possible biological barrier and fundamental issue is having a high enough analyte concentration in blood to measure and quantitate. As we gain more experience with this class and type of biomarker it is expected that technical advances will enable additional liquid biopsy applications in the clinical setting.